These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Reversible cerebral vasoconstriction syndrome in association with fingolimod use. Belliston S; Sundararajan J; Hammond N; Newell K; Lynch S Int J Neurosci; 2017 Sep; 127(9):831-834. PubMed ID: 27819760 [TBL] [Abstract][Full Text] [Related]
16. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Ducros A; Boukobza M; Porcher R; Sarov M; Valade D; Bousser MG Brain; 2007 Dec; 130(Pt 12):3091-101. PubMed ID: 18025032 [TBL] [Abstract][Full Text] [Related]
17. Headache as a crucial symptom in the etiology of convexal subarachnoid hemorrhage. Rico M; Benavente L; Para M; Santamarta E; Pascual J; Calleja S Headache; 2014 Mar; 54(3):545-50. PubMed ID: 23981007 [TBL] [Abstract][Full Text] [Related]
18. Reversible cerebral vasoconstriction syndrome and cervical artery dissection in 20 patients. Mawet J; Boukobza M; Franc J; Sarov M; Arnold M; Bousser MG; Ducros A Neurology; 2013 Aug; 81(9):821-4. PubMed ID: 23884040 [TBL] [Abstract][Full Text] [Related]
19. The Spectrum of Nontraumatic Convexity Subarachnoid Hemorrhage. Forman R; Conners JJ; Song SY; John S; Garg R; Harris J; Lee VH J Stroke Cerebrovasc Dis; 2019 Dec; 28(12):104473. PubMed ID: 31677961 [TBL] [Abstract][Full Text] [Related]
20. Transcranial Doppler Ultrasonography As a Non-Invasive Tool for Diagnosis and Monitoring of Reversible Cerebral Vasoconstriction Syndrome. Levin JH; Benavides J; Caddick C; Laurie K; Wilterdink J; Yaghi S; Silver B; Khan M R I Med J (2013); 2016 Sep; 99(9):38-41. PubMed ID: 27579950 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]